Market Research Report
Middle East and Africa Liposome Drug Delivery Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product ; Technology ; Application, and Country
|Published by||The Insight Partners||Product code||979147|
|Published||Content info||125 Pages
Delivery time: 1-2 business days
|Middle East and Africa Liposome Drug Delivery Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product ; Technology ; Application, and Country|
|Published: November 13, 2020||Content info: 125 Pages||
The Liposome are novel drug delivery system (NDDS), they are vesicular structures consisting of bilayers which form spontaneously when phospholipids are disappeared in water. They are microscopic vesicles in which an aqueous volume is entirely enclosed by a membrane composed of lipid bilayers.
Market Overview and Dynamics
The Middle East and Africa Liposome Drug Delivery market is expected to reach US$ 327.97 million by 2027 from US$ 162.83 million in 2019. The market is anticipated to grow with a CAGR of 9.3 % from 2019 to 2027. Increasing Prevalence of chronic diseases, increasing demand for non-invasive drug delivery system along with rising R&D expenditures by pharmaceutical companies are some of the driving force of the market. Whereas, high cost associated with development of Non-invasive drug delivery system is about to hinder the market growth during forecast period.
Key Market Segments
In The liposome drug delivery market is mainly segmented on the basis of products, technology and applications. The products are liposomal doxorubicin, liposomal Paclitaxel. On basis of technology it is segmented as stealth liposome technology, Depofoam liposome technology and others. And the final segmentation is on the application such as its usage in cancer therapy, fungal diseases, and pain management.
Major Sources and Companies Listed
Some of the major primary and secondary sources for Liposome drug delivery market included in the report are Food and Drug Administration (FDA), World health Organization (WHO) and others.
MIDDLE EAST AND AFRICA LIPOSOME DRUG DELIVERY MARKET SEGMENTATION
Liposomal Amphotericin B
Stealth liposome technology
Depofoam liposome technology
Non-PEGylated liposome Technology
Lysolipid thermally Sensitive Liposome Technology
Takeda pharmaceutical company
Luye pharma group
To understand the middle east and africa liposome drug delivery market landscape and identify market segments that are most likely to guarantee a strong returnStay ahead of the race by comprehending the ever-changing competitive landscape for middle east and africa liposome drug delivery marketEfficiently plan m&a and partnership deals in liposome drug delivery market by identifying market segments with the most promising probable salesHelps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form middle east and africa liposome drug delivery marketObtain market revenue forecast for market by various segments from 2019 to 2027 in middle east and africa region